Oral toxicities secondary to targeted therapies in patients with cancer: a large retrospective analysis.
Researchers analysed records from over 12,000 cancer patients receiving targeted therapies and found that oral mucosal lesions and dry mouth occurred in approximately 5% of cases, with rates lower than those reported in prospective clinical trials.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Managing the Pregnant Dental Patient
Confident, evidence-based dental care from the first trimester to the postpartum period
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall